Inhibrx Operating Cycle from 2010 to 2024

INBX Stock  USD 15.00  0.08  0.53%   
Inhibrx Operating Cycle yearly trend continues to be fairly stable with very little volatility. Operating Cycle is likely to outpace its year average in 2024. During the period from 2010 to 2024, Inhibrx Operating Cycle regression line of annual values had r-squared of  0.40 and arithmetic mean of (455.88). View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
-3.4 K
Current Value
-3.2 K
Quarterly Volatility
1.2 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Inhibrx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inhibrx's main balance sheet or income statement drivers, such as Interest Expense of 33.4 M, Minority Interest of 0.0 or Tax Provision of 2.6 K, as well as many indicators such as Price To Sales Ratio of 1 K, Dividend Yield of 0.0021 or PTB Ratio of 43.23. Inhibrx financial statements analysis is a perfect complement when working with Inhibrx Valuation or Volatility modules.
  
Check out the analysis of Inhibrx Correlation against competitors.
For more information on how to buy Inhibrx Stock please use our How to Invest in Inhibrx guide.

Latest Inhibrx's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Inhibrx over the last few years. It is Inhibrx's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inhibrx's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Inhibrx Operating Cycle Regression Statistics

Arithmetic Mean(455.88)
Geometric Mean91.54
Coefficient Of Variation(257.08)
Mean Deviation783.64
Median46.25
Standard Deviation1,172
Sample Variance1.4M
Range3.5K
R-Value(0.63)
Mean Square Error892,331
R-Squared0.40
Significance0.01
Slope(165.07)
Total Sum of Squares19.2M

Inhibrx Operating Cycle History

2024 -3225.33
2023 -3395.09
2022 10.11
2021 -74.24
2020 -624.52
2019 42.02
2018 58.79

About Inhibrx Financial Statements

Inhibrx investors use historical fundamental indicators, such as Inhibrx's Operating Cycle, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Inhibrx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cycle-3.4 K-3.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Inhibrx Stock Analysis

When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.